iBio (IBIO) Shares Outstanding (2010 - 2026)
iBio's (IBIO) quarterly Shares Outstanding (Entity) came in at $125590.0 in Q2 2020, up 211.6% year-on-year from $40305.0 in Q3 2019, and up 169616.22% on a QoQ basis from $74.0 in Q4 2019.
iBio (IBIO) Shares Outstanding (2010 - 2026) Analysis & Trends
iBio (IBIO) has 11 years of Shares Outstanding (Entity) data on file, last reported at $125590.0 in Q2 2020.
- On a quarterly basis, Shares Outstanding (Entity) rose 211.6% year-over-year to $125590.0 in Q2 2020; TTM through Jun 2020 was $125590.0, a 211.6% increase from a year earlier, with the FY2020 full-year figure at $125590.0, up 211.6% from the prior year.
- Shares Outstanding (Entity) for Q2 2020 stood at $125590.0, up from $74.0 in the prior quarter.
- Over the last five years, Shares Outstanding (Entity) for IBIO reached as high as $125590.0 in Q2 2020 and fell as low as $44.0 in Q3 2019.
- Historically, Shares Outstanding (Entity) has averaged $27722.1 across 5 years, with a median of $18564.0 in 2017.
- Across the five-year window, Shares Outstanding (Entity) tumbled 99.88% in 2019 and jumped 211.6% in 2020, its largest moves.
- Year by year, Shares Outstanding (Entity) stood at $17822.0 in 2016, then advanced by 29.41% to $23064.0 in 2017, then jumped by 63.35% to $37674.0 in 2018, then tumbled by 99.8% to $74.0 in 2019, then surged by 169616.22% to $125590.0 in 2020.
- Per Business Quant data, the three most recent Shares Outstanding (Entity) figures were $125590.0 in Q2 2020, $74.0 in Q4 2019, and $44.0 in Q3 2019.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,899.61 Bn | 65,899.33 Bn | - | 6,012.74 Bn |
| 2 | Nanobiotix | 1,933.82 Bn | 1,933.76 Bn | - | 47.82 Bn |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | 118.76 Bn |
| 4 | BeOne Medicines | 471.67 Bn | 466.88 Bn | 1.35 Bn | 1.44 Bn |
| 5 | Vertex Pharmaceuticals | 122.32 Bn | 115.07 Bn | 2.59 Bn | 254.10 Mn |
| 6 | Regeneron Pharmaceuticals | 70.04 Bn | 61.29 Bn | 3.31 Bn | 104.00 Mn |
| 7 | Belite Bio | 62.06 Bn | 62.06 Bn | - | 400.00 Mn |
| 8 | Argenx Se | 55.93 Bn | 50.74 Bn | 1.41 Bn | 62.19 Mn |
| 9 | Alnylam Pharmaceuticals | 37.55 Bn | 34.54 Bn | 959.66 Mn | 132.89 Mn |
| 10 | iBio | 166.84 Mn | 166.84 Mn | - | 119.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 119.60 Mn |
| Dec 31, 2025 | 99.13 Mn |
| Sep 30, 2025 | 52.98 Mn |
| Jun 30, 2025 | 10.50 Mn |
| Mar 31, 2025 | 9.86 Mn |
| Dec 31, 2024 | 9.13 Mn |
| Sep 30, 2024 | 8.63 Mn |
| Jun 30, 2024 | 3.83 Mn |
| Mar 31, 2024 | 3.71 Mn |
| Dec 31, 2023 | 1.86 Mn |
| Sep 30, 2023 | 1.20 Mn |
| Jun 30, 2023 | 612,250.00 |
| Mar 31, 2023 | 659,200.00 |
| Dec 31, 2022 | 490,350.00 |
| Sep 30, 2022 | 442,100.00 |
| Jun 30, 2022 | 436,050.00 |
| Mar 31, 2022 | 436,192.00 |
| Dec 31, 2021 | 435,980.00 |
| Sep 30, 2021 | 435,752.00 |
| Jun 30, 2021 | 391,240.00 |